Physician profile
Alex Gilde
NPI 1548674625
$2,528.70
in general payments reported to CMS, 2019-2025
15 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,016 · 2020: $610 · 2021: $149 · 2022: $278 · 2023: $79.01 · 2024: $278 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $883.79 | 2019-2024 | Rosa, Persona, Gel-One Cross-Linked Hyaluronate |
| Medtronic USA, INC. | $384.61 | 2019-2020 | |
| Medical Device Business Services, INC. | $373.30 | 2019 | |
| Stryker Corporation | $225.17 | 2019-2022 | |
| Depuy Synthes Sales INC. | $193.32 | 2019-2022 | |
| Wright Medical Technology, INC. | $100.05 | 2019-2020 | |
| Heron Therapeutics, INC. | $88.77 | 2023-2025 | Zynrelef |
| Acumed LLC | $84.02 | 2024 | Acumed, Innate Implant, Inframe Implant |
| Ethicon US, LLC | $63.14 | 2020-2025 | Ethicon, Vistaseal |
| Davol INC. | $49.09 | 2025 | Arista |
| Bioventus LLC | $19.65 | 2025 | Exogen Ultrasound Bone Healing System |
| Fidia Pharma USA INC. | $16.56 | 2020 | |
| Sanofi-Aventis U.S. LLC | $16.10 | 2023 | |
| Orthofix Medical, INC. | $15.91 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Gilde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.